Original paper
Serum uric acid and 11.5-year mortality of middle-aged women: Findings of the Chicago heart association detection project in industry

https://doi.org/10.1016/0895-4356(89)90061-9Get rights and content

Abstract

The relationships of serum uric acid to mortality from all causes, the cardiovascular diseases, and cancer were evaluated in 6797 white women age 35–64 years followed for an average of 11.5 years in the Chicago Heart Association Detection Project in Industry (CHA). Serum uric acid levels at baseline were strongly and significantly associated with all causes mortality in this cohort, with control for multiple risk factors and with exclusion of hypertensives on treatment. When the analysis was performed on age-specific groups 35–44, 45–54, and 55–64 years of age, the association was observed primarily in women in the oldest age group. All cardiovascular deaths, deaths due to coronary heart disease, and all cancer deaths were also associated with serum uric acid levels in the 55–64 year old group. The relationships persisted with control for multiple risk factors and with exclusion of treated hypertensives. A site-specific analysis of cancer deaths demonstrated elevations in mean serum uric acid levels for nearly all sites. Differences in mean serum uric acid levels between decedents and survivors tended to be largest in the first 5 years of follow-up for the cardiovascular deaths, but for cancer decedents they tended to be larger for subsequent years of follow-up. As an initial report on the association of serum uric acid and cancer in women in this age group, the results of this study require confirmation. Although hormonal influences may play a role, pathophysiologic mechanisms relating serum uric acid to mortality in white women aged 55–64 are currently unknown.

References (50)

  • V.W. Persky et al.

    Uric acid: a risk factor for coronary heart disease?

    Circulation

    (1979)
  • W.B. Kannel et al.

    Menopause and risk of cardiovascular disease

    Ann Intern Med

    (1976)
  • T. Gordon et al.

    Menopause and coronary heart disease: The Framingham study

    Ann Intern Med

    (1978)
  • F. de Waard et al.

    The bimodal age distribution of patients with mammary carcinoma: evidence for the existence of 2 types of human breast cancer

    Cancer

    (1964)
  • S.P. Helmrich et al.

    Risk factors for breast cancer

    Am J Epidemiol

    (1983)
  • H.-O. Adami et al.

    The relation between survival and age at diagnosis of breast cancer

    N Engl J Med

    (1986)
  • W.M. Mikkelsen et al.

    The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia

    Am J Med

    (1975)
  • H. Isomaki

    Hyperuricemia in Northern Finland. An epidemiological study of serum uric acid in rural, urban and hospital populations

    Ann Clin Res

    (1969)
  • C. Bengtsson et al.

    Serum uric acid levels in women

    Acta Med Scand

    (1974)
  • S. Akizuki

    Serum uric acid levels among thirty-four thousand people in Japan

    Ann Rheum Dis

    (1982)
  • D. Adamopoulos et al.

    The relationships of sex steroids to uric acid levels in plasma and urine

    Acta Endocrinol

    (1977)
  • P.B. Hawk et al.

    Practical Physiological Chemistry

  • US Department of Health, Education, and Welfare et al.

    International Classification of Diseases (8th revision) adapted for use in the United States (ICDA)

  • M. Norusis

    PSS/PC+: SPSS for the IBM PC/XT/AT

    (1986)
  • D.R. Cox

    Regression models and life tables

    J R Stat Soc Ser B

    (1972)
  • Cited by (197)

    • Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies

      2020, Atherosclerosis
      Citation Excerpt :

      The results of the quality assessment are shown in the Supplemental Table 3. Only one study had score 5 [6], whereas 5 studies had score 6 [18,22,23,49,50] and 28 studies score ≥ 7. A positive and significant association was found between SUA levels and all-cause mortality (RR: 1.21, 1.07–1.37, p = 0.002, n = 15 studies, Fig. 2), with no risk of heterogeneity (I2:36.4, p = 0.124).

    View all citing articles on Scopus
    View full text